B

BioNote Inc
KRX:377740

Watchlist Manager
BioNote Inc
KRX:377740
Watchlist
Price: 4 600 KRW -2.13% Market Closed
Market Cap: 469.1B KRW
Have any thoughts about
BioNote Inc?
Write Note

BioNote Inc
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

BioNote Inc
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
B
BioNote Inc
KRX:377740
Other Long-Term Assets
â‚©491.4m
CAGR 3-Years
7%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Other Long-Term Assets
â‚©143.9B
CAGR 3-Years
36%
CAGR 5-Years
26%
CAGR 10-Years
21%
SK Bioscience Co Ltd
KRX:302440
Other Long-Term Assets
â‚©88.3B
CAGR 3-Years
62%
CAGR 5-Years
46%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Other Long-Term Assets
â‚©31.1B
CAGR 3-Years
39%
CAGR 5-Years
34%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Other Long-Term Assets
â‚©9.8B
CAGR 3-Years
28%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Other Long-Term Assets
â‚©2.7B
CAGR 3-Years
417%
CAGR 5-Years
45%
CAGR 10-Years
N/A
No Stocks Found

BioNote Inc
Glance View

Market Cap
469.5B KRW
Industry
Biotechnology

BioNote, Inc. develops veterinary diagnostic composition. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2022-12-22. The firm is engaged in the manufacture and sale of rapid diagnostic kits for humans, diagnosis raw materials such as antigens, antibody cell lines, standards, enzymes and others as well as semi-finished products. The firm is also engaged in the manufacture and sale of rapid immunochemical diagnosis, enzyme immune rebound protein, immunochemical fluorescence diagnosis and other products used for animals.

Intrinsic Value
6 138.02 KRW
Undervaluation 25%
Intrinsic Value
Price
B

See Also

What is BioNote Inc's Other Long-Term Assets?
Other Long-Term Assets
491.4m KRW

Based on the financial report for Dec 31, 2023, BioNote Inc's Other Long-Term Assets amounts to 491.4m KRW.

What is BioNote Inc's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 3Y
7%

Over the last year, the Other Long-Term Assets growth was 213%. The average annual Other Long-Term Assets growth rates for BioNote Inc have been 7% over the past three years .

Back to Top